Elevated glucose level adversely affects infarct volume growth and neurological deterioration in non-diabetic stroke patients, but not diabetic stroke patients

European Journal of Neurology

Volumn 21, Issue 3, 2014, Pages 402-410

  Shimoyama, T ^a   Kimura, K ^a   Uemura, J ^a   Saji, N ^a   Shibazaki, K ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Cerebral infarction; Diabetes; MRI

Indexed keywords

CEREBRAL INFARCTION; DIABETES; MRI;

AGED; AGED, 80 AND OVER; BRAIN INFARCTION; DIABETES COMPLICATIONS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STROKE;

EID: 84893871550     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12280     Document Type: Article

References (24)

1. Uyttenboogaart M, Koch MW, Stewart RE, Vroomen PC, Luijckx GJ, De Keyser J. Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. Brain 2007; 130: 1626-1630.
2. Kiers L, Davis SM, Larkins R, et al. Stroke topography and outcome in relation to hyperglycemia and diabetes. J Neurol Neurosurg Psychiatry 1992; 55: 263-270.
3. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426-2432.
4. Dungan KM, Braithwaite SS, Preiser J-C. Stress hyperglycaemia. Lancet 2009; 373: 1798-1807.
5. Kimura K, Sakamoto Y, Iguchi Y, et al. Admission hyperglycemia and serial infarct volume after t-PA therapy in patients with and without early recanalization. J Neurol Sci 2011; 307: 55-59.
6. Ribo M, Molina CA, Delgado P, et al. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. J Cereb Blood Flow Metab 2007; 27: 1616-1622.
7. Mori M, Naganuma M, Okada Y, et al. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Cerebrovasc Dis 2012; 34: 140-146.
8. Ribo M, Molina CA, Montaner J, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 2005; 36: 1705-1709.
9. Melikian N, Seddon MD, Casadei B, Chowienczyk PJ, Shah AM. Neuronal nitric oxide synthase and human vascular regulation. Trends Cardiovasc Med 2009; 19: 256-262.
10. Kamada H, Yu F, Nito C, Chan PH. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 2007; 38: 1044-1049.
11. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52: 20-28.
12. Paciaroni M, Agnelli G, Caso V, et al. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis 2009; 28: 119-123.
13. Zhang WW, Zhang L, Hou WK, et al. Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion. Chin Med J (Engl) 2009; 122: 1996-2001.
14. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
15. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010; 33: 562-568.
16. Rosso C, Corvol JC, Pires C, et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke 2012; 43: 2343-2349.
17. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T. Atrial fibrillation as an independent predictor for no early recanalization after iv-t-PA in acute ischemic stroke. J Neurol Sci 2008; 267: 57-61.
18. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001; 32: 438-441.
19. Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 2003; 89: 3-9.
20. Vannucci SJ, Clark RR, Koehler-Stec E, Li K, Smith CB, Davies P. Glucose transporter expression in brain: relationship to cerebral glucose utilization. Dev Neurosci 1998; 20: 369-379.
21. Lawrence MS, Sun GH, Kunis DM, et al. Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J Cereb Blood Flow Metab 1996; 16: 181-185.
22. Devaskar SU, Rajakumar PA, Mink RB, Mcknight RA, Thamotharan S, Hicks SJ. Effect of development and hypoxic-ischemia upon rabbit brain glucose transporter expression. Brain Res 1999; 823: 113-128.
23. Duelli R, Maurer MH, Staudt R, Heiland S, Duembgen L, Kuschinsky W. Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain. Brain Res 2000; 858: 338-347.
24. Alvarez-Sabín J, Molina CA, Ribó M, et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 2004; 35: 2493-2498.